Scalpel secures Pre-Series A funding from Henley Business Angels
Henley Business Angels backs healthcare technology firm Scalpel in its latest funding round.
Scalpel provides sensor-driven event detection technology to automate surgical protocols and streamline hospital operations.
Scalpel has secured Pre-Series A funding from Henley Business Angels members to support its next phase of growth. The company automates surgical protocols in operating rooms using sensor-driven event detection and AI platforms, helping hospitals reduce inefficiencies and improve patient safety.
The newly secured capital will be directed towards deploying the technology across several new sites. Additionally, Scalpel intends to increase data collection and model training, as well as launch multi-site clinical trials to expand its research and development efforts.
The business already generates revenue through one-off installations and monthly software subscriptions, having agreed deals with multiple NHS Hospital Trusts.
From the founder
"We are excited to work with strategic investors who can support the business beyond just cash."
Yesh Pulijala
Co-founder and CEO at Scalpel
Investor perspective
"Scalpel has developed an innovative solution to address the growing problems faced by our healthcare system of lengthening operating lists and longer waiting times. HBA members were persuaded that the Scalpel solution has the potential to improve efficiency and enable hospitals to perform more operations and do so more safely."
Jurek Sikorski
Founder and Director, Henley Business Angels
Use of funds
- 01Fund research and development
- 02Expand into international markets
